K

Krystal Biotech

Dermatology-focused topical gene therapies

Quality Control Analyst 1

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timePittsburgh, PA, USANo salary listedIn-person

About the Job

Requirements

  • A bachelor's degree in life science is required.
  • Experience with mammalian cell culture, plaque titer, enzyme-linked immunosorbent assay (ELISA), quantitative polymerase chain reaction (qPCR), Southern blot, and Western blot techniques.
  • Proficiency in Microsoft Word, Excel, and PowerPoint.
  • Environmental monitoring experience is a plus but is not required.
  • Ability to address changing priorities and take a proactive approach to work.
  • Ability to work with a dynamic team.
  • Scientific writing skills and written and oral communication skills are required.

Responsibilities

  • Perform complex analytical testing for the release of drug products for clinical and commercial use.
  • Conduct finished product testing and stability testing, and report QC results to management.
  • Review analytical data and notify management when data fall outside prescribed acceptance criteria or specifications.
  • Support laboratory investigations, deviation investigations, corrective and preventive action (CAPA), and change requests (CR) as required by QC Management.
  • Initiate and complete clinical laboratory investigations as required.
  • Participate in analytical method validation and/or method transfer.
  • Support document control and record retention activities.
  • Facilitate material management, including purchasing, receipt, inventory, storage, and sampling.
  • Maintain QC laboratory equipment through equipment standard operating procedures, working with QC Supervisors.
  • Participate in QC projects as needed and instructed.
  • Participate in global audits as required.
  • Maintain all QC laboratory spaces in an audit-ready state.
  • Perform other duties as assigned.

Desired Qualifications

  • Environmental monitoring experience.

About the Company

Krystal Biotech

Dermatology-focused topical gene therapies

Krystal Biotech develops and sells gene therapies for rare dermatological diseases. Its lead product, VYJUVEK (beremagene geperpavec-svdt), is a topical gene therapy designed to treat dystrophic epidermolysis bullosa (DEB) by delivering a corrected gene directly to the skin so that damaged skin can heal. The company’s STAR-D platform enables off-the-shelf gene therapies that can be used across a range of skin conditions and the VYJUVEK therapy is designed to be redoable, meaning its treatment can be repeated if needed. Krystal Biotech stands out by owning exclusive worldwide rights to its therapies and by being the first FDA-approved medicine for DEB, a rare condition. The company’s goal is to grow its portfolio of dermatology gene therapies using the STAR-D platform to provide accessible, repeatable treatments for patients with rare skin diseases.

Company size
201-500
Company stage
IPO
Headquarters
Pittsburgh, PA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Krystal Biotech

See more jobs